comparemela.com

Latest Breaking News On - Insider transactions at laboratory co - Page 9 : comparemela.com

Wells Fargo & Company Lowers Laboratory Co of America (NYSE:LH) Price Target to $270 00

Laboratory Co. of America (NYSE:LH – Get Free Report) had its price target dropped by investment analysts at Wells Fargo & Company from $290.00 to $270.00 in a research note issued on Monday, MarketBeat Ratings reports. The brokerage presently has an “overweight” rating on the medical research company’s stock. Wells Fargo & Company‘s target price […]

KCM Investment Advisors LLC Has $7 79 Million Stake in Laboratory Co of America Holdings (NYSE:LH)

KCM Investment Advisors LLC decreased its holdings in Laboratory Co. of America Holdings (NYSE:LH – Free Report) by 5.1% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 33,947 shares of the medical research company’s stock after selling 1,832 shares during the quarter. KCM […]

KCM Investment Advisors LLC Lowers Stock Holdings in Laboratory Co of America Holdings (NYSE:LH)

KCM Investment Advisors LLC reduced its position in Laboratory Co. of America Holdings (NYSE:LH – Free Report) by 5.1% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 33,947 shares of the medical research company’s stock after selling 1,832 shares during the period. KCM Investment Advisors LLC’s holdings […]

Equitable Trust Co Buys 20,332 Shares of Laboratory Co of America Holdings (NYSE:LH)

Equitable Trust Co. boosted its holdings in Laboratory Co. of America Holdings (NYSE:LH – Free Report) by 36.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 76,549 shares of the medical research company’s stock after buying an additional 20,332 shares during the period. […]

Laboratory Co of America (NYSE:LH) Price Target Cut to $260 00 by Analysts at Morgan Stanley

Laboratory Co. of America (NYSE:LH – Free Report) had its target price reduced by Morgan Stanley from $285.00 to $260.00 in a report released on Thursday morning, Benzinga reports. They currently have an overweight rating on the medical research company’s stock. Other equities analysts also recently issued research reports about the company. Citigroup dropped their […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.